Search Results - "Furlan, Thaísa Kowalski"
-
1
Certolizumab Pegol in Crohn's Disease Management: A Multicentric Brazilian Observational Study
Published in Journal of Coloproctology (01-09-2024)“…Introduction and Objectives Certolizumab Pegol (CZP) is an anti-TNF agent approved in Brazil for Crohn's disease (CD). There is a lack of data in Brazil and…”
Get full text
Journal Article -
2
USTEKINUMAB IN CROHN'S DISEASE MANAGEMENT: A BRAZILIAN OBSERVATIONAL STUDY
Published in Arquivos de gastroenterologia (01-12-2022)“…Real-world data on the use of Ustekinumab (UST) in Brazilian and Latin American patients with Crohn's disease (CD) are scarce. The primary endpoint was…”
Get full text
Journal Article -
3
Anti-TNF therapy for ulcerative colitis in Brazil: a comparative real-world national retrospective multicentric study from the Brazilian study group of IBD (GEDIIB)
Published in BMC gastroenterology (29-05-2022)“…Anti-TNF therapy represented a landmark in medical treatment of ulcerative colitis (UC). There is lack of data on the efficacy and safety of these agents in…”
Get full text
Journal Article -
4
Tonsillar Crohn's Disease
Published in United European gastroenterology journal (25-11-2024)Get full text
Journal Article -
5
USTEKINUMAB IN CROHN'S DISEASE MANAGEMENT: A BRAZILIAN OBSERVATIONAL STUDY
Published in Arquivos de gastroenterologia (01-10-2022)“…Real-world data on the use of Ustekinumab (UST) in Brazilian and Latin American patients with Crohn's disease (CD) are scarce. The primary endpoint was…”
Get full text
Journal Article -
6
CERTOLIZUMABE PEGOL NA DOENÇA DE CROHN: UM ESTUDO OBSERVACIONAL MULTICÊNTRICO
Published in Journal of Coloproctology (01-12-2022)Get full text
Conference Proceeding